↓ Skip to main content

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

Overview of attention for article published in Current Neuropharmacology, November 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 512)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
6 news outlets
blogs
2 blogs
policy
1 policy source
twitter
15 tweeters
facebook
1 Facebook page
wikipedia
3 Wikipedia pages
googleplus
1 Google+ user
video
1 video uploader

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
140 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Published in
Current Neuropharmacology, November 2014
DOI 10.2174/1570159x12666140619204251
Pubmed ID
Authors

Gianluca Serafini, Robert Howland, Fabiana Rovedi, Paolo Girardi, Mario Amore

Abstract

At least 10-20% of the patients suffering from depression meet criteria for treatment-resistant depression (TRD). In the last decades, an important role of glutamate in mood modulation has been hypothesized and ketamine, a non noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptors, has been demonstrated to be effective in both MDD and TRD. However, concerns emerged about the optimal dosage, and frequency of administration of this treatment.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Poland 1 <1%
Mexico 1 <1%
New Zealand 1 <1%
Unknown 135 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 31 22%
Student > Master 20 14%
Researcher 18 13%
Unspecified 15 11%
Other 12 9%
Other 44 31%
Readers by discipline Count As %
Medicine and Dentistry 43 31%
Unspecified 22 16%
Neuroscience 19 14%
Psychology 19 14%
Agricultural and Biological Sciences 15 11%
Other 22 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 87. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2019.
All research outputs
#197,523
of 13,879,760 outputs
Outputs from Current Neuropharmacology
#7
of 512 outputs
Outputs of similar age
#4,233
of 299,842 outputs
Outputs of similar age from Current Neuropharmacology
#1
of 15 outputs
Altmetric has tracked 13,879,760 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 512 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 299,842 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.